Hospital Mater Dei S.A. Share Price

Equities

MATD3

BRMATDACNOR4

Healthcare Facilities & Services

Market Closed - Sao Paulo 21:06:00 30/04/2024 BST 5-day change 1st Jan Change
5.68 BRL -3.40% Intraday chart for Hospital Mater Dei S.A. +4.41% -31.98%

Financials

Sales 2024 * 2.48B 477M 38.06B Sales 2025 * 2.83B 545M 43.52B Capitalization 2.17B 418M 33.35B
Net income 2024 * 171M 32.93M 2.63B Net income 2025 * 276M 53.14M 4.24B EV / Sales 2024 * 1.6 x
Net Debt 2024 * 1.8B 346M 27.61B Net Debt 2025 * 1.5B 290M 23.12B EV / Sales 2025 * 1.3 x
P/E ratio 2024 *
11.8 x
P/E ratio 2025 *
7.04 x
Employees 3,500
Yield 2024 *
2.05%
Yield 2025 *
3.12%
Free-Float 28.36%
More Fundamentals * Assessed data
Dynamic Chart
Hospital Mater Dei S.A. announces an Equity Buyback for 9,613,168 shares, representing 2.51% of its issued share capital. CI
Hospital Mater Dei S.A. authorizes a Buyback Plan. CI
Hospital Mater Dei S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Hospital Mater Dei S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Hospital Mater Dei S.A.'s Equity Buyback announced on July 13, 2022 has expired. CI
Hospital Mater Dei S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Hospital Mater Dei S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Hospital Mater Dei S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Hospital Mater Dei S.A. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Hospital Mater Dei S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
Hospital Mater Dei S.A. completed the acquisition of 95.5% stake in Hospital Premium. CI
Hospital Mater Dei S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Hospital Mater Dei S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Hospital Mater Dei S.A. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Hospital Mater Dei S.A. agreed to acquire unknown majority stake in hospital Maternidade Santa Clara Ltda for an enterprise value of approximately BRL 230 million. CI
More news
1 day-3.40%
1 week+4.41%
Current month-2.74%
1 month+0.35%
3 months-12.48%
6 months-18.62%
Current year-31.98%
More quotes
1 week
5.30
Extreme 5.3
6.00
1 month
5.24
Extreme 5.24
6.00
Current year
5.24
Extreme 5.24
8.40
1 year
5.24
Extreme 5.24
11.33
3 years
5.24
Extreme 5.24
21.79
5 years
5.24
Extreme 5.24
21.79
10 years
5.24
Extreme 5.24
21.79
More quotes
Managers TitleAgeSince
Chief Executive Officer 65 31/12/85
Director of Finance/CFO 42 31/03/03
Chief Operating Officer 37 -
Members of the board TitleAgeSince
Director/Board Member 86 -
Director/Board Member 65 -
Director/Board Member 70 -
More insiders
Date Price Change Volume
30/04/24 5.68 -3.40% 606,700
29/04/24 5.88 +2.98% 880,800
26/04/24 5.71 +4.96% 208,000
25/04/24 5.44 +0.74% 156,600
24/04/24 5.4 -0.74% 615,800

Delayed Quote Sao Paulo, April 30, 2024 at 09:06 pm

More quotes
Hospital Mater Dei SA is a Brazil-based company that is part of the Mater Dei Health Network, an integrated platform for the provision of hospital and cancer services, one of the largest hospitals in Minas Gerais in terms of number of private beds, also operating in the states of Bahia, Para and Goias. The Company has hospital beds distributed in its four units strategically located in the metropolitan region of Belo Horizonte and in Belem, in addition to hospital beds in the Hospital de Salvador/BA, Hospital Santa Genoveva in Uberlandia/MG, Hospital Premium in Goiania/GO and Hospital EMEC in Feira de Santana/BA. The Company provides services to several independent and self-managed health plan operators, such as: Allianz, Amil, Bacen, Bradesco Saude, Caixa Economica Federal, Care Plus, Cassi, Copass, FCA Saude, Golden Cross, IPSM, Sul America, Vale, among many others.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
5.68 BRL
Average target price
9.975 BRL
Spread / Average Target
+75.62%
Consensus